This study is testing whether a new drug called VYD2311 can prevent people from getting COVID-19. About 1,770 adults and teens aged 12+ will receive three monthly shots of either VYD2311 or a placebo. Researchers will track who gets sick over 90 days to see if the drug lowers inf…
Phase: PHASE3 • Sponsor: Invivyd, Inc. • Aim: Prevention
Last updated Mar 27, 2026 12:37 UTC